Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.7249
+0.00110.15%
Post-market: 0.74420.0193+2.66%19:53 EDT
Volume:120.37K
Turnover:88.12K
Market Cap:54.62M
PE:-1.11
High:0.7514
Open:0.7300
Low:0.7200
Close:0.7238
Loading ...
Mar 27, 2020

Major Issues Report

8-K - Current report
Mar 17, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 12, 2020

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 18, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Nov 26, 2019

Major Issues Report

Current report, items 1.01, 1.02, and 9.01
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 09, 2019

Major Issues Report

Current report, item 5.02
Oct 07, 2019

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 5.02 and 5.07
Jul 09, 2019

Correspondence

[Cover]Correspondence
Jul 09, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]